Richard A. Scotland

Richard A. Scotland appears in our data through filings on GTC Biotherapeutics Inc shares, published by SEC (Form 4). Between 10 March 2006 and 9 February 2010, the trades on record add up to 20 filings.

In open-market terms, that means 1 purchase worth €12k on one side and 1 sale worth €12k on the other. Netting one side against the other leaves €113 of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 10 share grants. Since January 2010: 1 purchase and 1 sale on the market.

Most recently, on 12 February 2010, the filings show an open-market purchase worth €12k in GTC Biotherapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.